6.
Pieterman C, Valk G
. Update on the clinical management of multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf). 2022; 97(4):409-423.
PMC: 9540817.
DOI: 10.1111/cen.14727.
View
7.
Mele C, Brunani A, Damascelli B, Ticha V, Castello L, Aimaretti G
. Non-surgical ablative therapies for inoperable benign insulinoma. J Endocrinol Invest. 2017; 41(2):153-162.
DOI: 10.1007/s40618-017-0738-3.
View
8.
McComb K, Roulston G, Armstrong L
. Insulinoma: an uncommon cause of delirium. Age Ageing. 2022; 51(3).
DOI: 10.1093/ageing/afac055.
View
9.
Maggio I, Mollica V, Brighi N, Lamberti G, Manuzzi L, Ricci A
. The functioning side of the pancreas: a review on insulinomas. J Endocrinol Invest. 2019; 43(2):139-148.
DOI: 10.1007/s40618-019-01091-w.
View
10.
Hirshberg B, Livi A, Bartlett D, Libutti S, Alexander H, Doppman J
. Forty-eight-hour fast: the diagnostic test for insulinoma. J Clin Endocrinol Metab. 2000; 85(9):3222-6.
DOI: 10.1210/jcem.85.9.6807.
View
11.
Hofland J, Refardt J, Feelders R, Christ E, de Herder W
. Approach to the Patient: Insulinoma. J Clin Endocrinol Metab. 2023; 109(4):1109-1118.
PMC: 10940262.
DOI: 10.1210/clinem/dgad641.
View
12.
Peltola E, Hannula P, Huhtala H, Metso S, Sand J, Laukkarinen J
. Long-term morbidity and mortality in patients diagnosed with an insulinoma. Eur J Endocrinol. 2021; 185(4):577-586.
PMC: 8784472.
DOI: 10.1530/EJE-21-0230.
View
13.
Lee D, Kim M, Kim H
. Diagnosis of Pancreatic Neuroendocrine Tumors. Clin Endosc. 2017; 50(6):537-545.
PMC: 5719919.
DOI: 10.5946/ce.2017.131.
View
14.
Etchebehere E, Santos A, Gumz B, Vicente A, Hoff P, Corradi G
. 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial. J Nucl Med. 2014; 55(10):1598-604.
DOI: 10.2967/jnumed.114.144543.
View
15.
Zhao Y, Yu J, Liu Y, Lyu L, Ping F, Xu L
. Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China. Orphanet J Rare Dis. 2022; 17(1):219.
PMC: 9195405.
DOI: 10.1186/s13023-022-02370-1.
View
16.
Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y
. Diagnosis and management of insulinoma. World J Gastroenterol. 2013; 19(6):829-37.
PMC: 3574879.
DOI: 10.3748/wjg.v19.i6.829.
View
17.
Crino S, Napoleon B, Facciorusso A, Lakhtakia S, Borbath I, Caillol F
. Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma. Clin Gastroenterol Hepatol. 2023; 21(11):2834-2843.e2.
DOI: 10.1016/j.cgh.2023.02.022.
View
18.
Sada A, Szabo Yamashita T, Glasgow A, Habermann E, Thompson G, Lyden M
. Comparison of benign and malignant insulinoma. Am J Surg. 2020; 221(2):437-447.
DOI: 10.1016/j.amjsurg.2020.08.003.
View